Literature DB >> 18080413

The multifunctional role of antibodies in the protective response to bacterial T cell-independent antigens.

J J Mond1, J F Kokai-Kun.   

Abstract

While most complex antigens can induce antibody responses in a mature immunological system, this is not the case when injected into ontogenetically immature systems, as are found in neonates and pediatric-age children. Thus the antibody response to polysaccharides, which would in theory provide protection against infection by all polysaccharide encapsulated bacteria, including Streptococcus pneumoniae, Neisseria meningitides, and Haemophilus influenzae, cannot be stimulated by immunization with the polysaccharides by themselves. It was only with the introduction of conjugate vaccines that protection from these bacterial infections was provided to this susceptible age group. The introduction of these conjugate vaccines into the arsenal of vaccines serves as a remarkable example of how valuable it is to understand the mechanisms of biological processes. Many years of intense laboratory investigation demonstrated that when polysaccharides are covalently conjugated to proteins, the characteristics of the immune response are similar to that of the protein rather than the polysaccharide. These characteristics would induce an anti-polysaccharide response even in the pediatric population, which was heretofore unable to mount protective responses to the polysaccharide. With the advent of conjugate vaccines for the above three mentioned bacteria, the incidence of bacteremia, meningitis, and otitis media has almost been eliminated. This chapter discusses in some detail the mechanisms which underlie the effectiveness of conjugate vaccines and discusses some of the vaccines that have been commercialized.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18080413     DOI: 10.1007/978-3-540-73900-5_2

Source DB:  PubMed          Journal:  Curr Top Microbiol Immunol        ISSN: 0070-217X            Impact factor:   4.291


  7 in total

Review 1.  Toll-like receptors and B-cell receptors synergize to induce immunoglobulin class-switch DNA recombination: relevance to microbial antibody responses.

Authors:  Egest J Pone; Hong Zan; Jingsong Zhang; Ahmed Al-Qahtani; Zhenming Xu; Paolo Casali
Journal:  Crit Rev Immunol       Date:  2010       Impact factor: 2.214

Review 2.  B cell TLRs and induction of immunoglobulin class-switch DNA recombination.

Authors:  Egest J Pone; Zhenming Xu; Clayton A White; Hong Zan; Paolo Casali
Journal:  Front Biosci (Landmark Ed)       Date:  2012-06-01

3.  BCR-signalling synergizes with TLR-signalling for induction of AID and immunoglobulin class-switching through the non-canonical NF-κB pathway.

Authors:  Egest J Pone; Jinsong Zhang; Thach Mai; Clayton A White; Guideng Li; John K Sakakura; Pina J Patel; Ahmed Al-Qahtani; Hong Zan; Zhenming Xu; Paolo Casali
Journal:  Nat Commun       Date:  2012-04-03       Impact factor: 14.919

Review 4.  Parasite Carbohydrate Vaccines.

Authors:  Jonnel A Jaurigue; Peter H Seeberger
Journal:  Front Cell Infect Microbiol       Date:  2017-06-12       Impact factor: 5.293

5.  Manganese salts function as potent adjuvants.

Authors:  Rui Zhang; Chenguang Wang; Yukun Guan; Xiaoming Wei; Mengyin Sha; Mengran Yi; Miao Jing; Mengze Lv; Wen Guo; Jing Xu; Yi Wan; Xin-Ming Jia; Zhengfan Jiang
Journal:  Cell Mol Immunol       Date:  2021-03-25       Impact factor: 11.530

6.  Immunobiologic and antiinflammatory properties of a bark extract from Ampelozizyphus amazonicus Ducke.

Authors:  Ligia Maria Torres Peçanha; Patricia Dias Fernandes; Tatiana Jotha-Mattos Simen; Danilo Ribeiro de Oliveira; Priscilla Vanessa Finotelli; Marina Vieira Agostinho Pereira; Fernanda Ferreira Barboza; Thays da Silva Almeida; Stephanie Carvalhal; Anna Paola Trindade Rocha Pierucci; Gilda Guimarães Leitão; Luca Rastrelli; Anna Lisa Piccinelli; Suzana Guimarães Leitão
Journal:  Biomed Res Int       Date:  2013-02-28       Impact factor: 3.411

7.  Characterization and Protective Activity of Monoclonal Antibodies Directed against Streptococcus suis Serotype 2 Capsular Polysaccharide Obtained Using a Glycoconjugate.

Authors:  Guillaume Goyette-Desjardins; Sonia Lacouture; Jean-Philippe Auger; René Roy; Marcelo Gottschalk; Mariela Segura
Journal:  Pathogens       Date:  2019-09-07
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.